The effects of imatinib on BSCB integrity are in agreement with the effects found in a mouse model of ischemic stroke, where imatinib promotes BBB integrity and reduces stroke volume by inhibiting PDGF-CC induced activation of PDGFR-α on perivascular astrocytic endfeet [8]. Here, PDGFRA is linked to stroke disorder.